Skip to main content
drug protocol number
CINC424A2401
drug sponsor
Novartis
drug study
Ruxolitinib
drug trial site
King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah)
drug status
Ongoing
drug phase